These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 19844125
1. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study. Romer T, Saenger P, Peter F, Walczak M, Le Bouc Y, Khan-Boluki J, Berghout A. Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125 [Abstract] [Full Text] [Related]
2. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study. López-Siguero J, Borrás Pérez MV, Balser S, Khan-Boluki J. Adv Ther; 2011 Oct; 28(10):879-93. PubMed ID: 21948492 [Abstract] [Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A. Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [Abstract] [Full Text] [Related]
4. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency. Peterkova V, Arslanoglu I, Bolshova-Zubkovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P. Horm Res; 2007 Aug; 68(6):288-93. PubMed ID: 17627092 [Abstract] [Full Text] [Related]
5. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis. Stanhope R, Sörgel F, Gravel P, Pannatier Schuetz YB, Zabransky M, Muenzberg M. J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088 [Abstract] [Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y. Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964 [Abstract] [Full Text] [Related]
7. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy. Mohn A, Marzio D, Giannini C, Capanna R, Marcovecchio M, Chiarelli F. Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806 [Abstract] [Full Text] [Related]
8. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial]. Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW. Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383 [Abstract] [Full Text] [Related]
9. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children? Lanes R, Jakubowicz S. J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186 [Abstract] [Full Text] [Related]
10. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
11. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth? Seminara S, Stagi S, Candura L, Scrivano M, Lenzi L, Nanni L, Pagliai F, Chiarelli F. Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229 [Abstract] [Full Text] [Related]
12. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS. Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [Abstract] [Full Text] [Related]
13. Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study. Iughetti L, Tornese G, Street ME, Napoli F, Giavoli C, Antoniazzi F, Stagi S, Luongo C, Azzolini S, Ragusa L, Bona G, Zecchino C, Aversa T, Persani L, Guazzarotti L, Zecchi E, Pietropoli A, Zucchini S. Ital J Pediatr; 2016 Nov 03; 42(1):93. PubMed ID: 27809913 [Abstract] [Full Text] [Related]
15. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment. Wu KH, Tsai FJ, Peng CT. Ann Hematol; 2003 Oct 03; 82(10):637-40. PubMed ID: 12898188 [Abstract] [Full Text] [Related]
16. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M. J Pediatr Gastroenterol Nutr; 2007 Oct 03; 45(4):433-7. PubMed ID: 18030209 [Abstract] [Full Text] [Related]
17. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S. J Med Assoc Thai; 2007 Oct 03; 90(10):2047-52. PubMed ID: 18041422 [Abstract] [Full Text] [Related]
18. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board. Horm Res; 2007 Oct 03; 68(2):53-62. PubMed ID: 17228181 [Abstract] [Full Text] [Related]